Dr. Navarini considers the wide range of non-pharmacological options available to treat psoriasis.
Dr. Conrad discusses if we can modify the disease course for psoriasis and if we are moving towards a cure.
Dr. Skov reviews what biomarkers are and how they can be used in future treatment development.
Panelist provide their expertise on current and future psoriasis treatments.
Dr. Schots reviews her research on the effectiveness and drug survival of an IL-17i in real-world experience.
Dr. Ghaffarinia highlights her research on epidermal keratinocytes and their role in disease memory.
Dr. Briatico discusses her research on adipose tissue and skin inflammation.